ABOLOGIX founded in Geneva, Switzerland
- branding425
- Jan 25, 2018
- 1 min read
Updated: Feb 28
Geneva, Switzerland, January 25, 2018 – Abologix, a privately held swiss biotechnology company developing novel immuno-oncology products for the benefit of cancer patients has been founded in Geneva, Switzerland by Dr. Ignacio Faus, Prof. Beat Imhof (University of Geneva) and Prof. Thomas Matthes (Geneva University Hospital ).
Comments